JSC "VERTEX" (St. Petersburg)
Production of finished dosage forms and parapharmaceuticals. The company's product portfolio includes more than 200 items. In 2015, a new production site was opened with a design capacity of more than 100 million packages per year.

CJSC "Biocad" (St. Petersburg, Moscow region)
Production of drugs for the treatment of infectious, viral, autoimmune and oncological diseases. Production sites are located in St. Petersburg and the Moscow region. The product portfolio includes 45 items.

Group of companies "GEROPHARM" (St. Petersburg, Moscow region)
Production of biotechnological drugs based on genetic engineering technologies, including insulin analogues, as well as other drugs for the treatment of social significant diseases. The product portfolio includes 10 drugs.

LLC "NTFF "POLYSAN" (St. Petersburg)
Development and implementation in medical practice Drugs of our own production. The company produces original drugs: Cycloferon, Reamberin, Cytoflavin and Remaxol.

Novartis Neva LLC (St. Petersburg)
The first plant of the Novartis group of companies in Russia. The planned production capacity is 1.5 billion units of solid dosage forms per year.

Grotex LLC (Solopharm) (St. Petersburg)
Specialization in the production of liquid sterile dosage forms. The Solopharm plant was put into operation in 2013. The design capacity is more than 1 billion units of products per year.

CJSC "Active Component" (St. Petersburg)
Production of active pharmaceutical substances. More than 30 types of API.

LLC "NPF "KEM" (St. Petersburg)
Industrial chemical synthesis of drug substances. Substances: Dioxidin, Diazolin, Arbidol, Meldonium, Pantogam, Proxadolol, etc.

SKTB "Technolog" (St. Petersburg)
Production of TOS products, composite materials and devices, medicinal substances, polymer compositions

PJSC "Pharmsintez" (St. Petersburg)
Production of fine organic synthesis products (TOS) and active pharmaceutical ingredients (API).

Pharmamed LLC (St. Petersburg)
Release of FPP (Nitroglycerin, Valemidin); Production of active pharmaceutical ingredients (unithiol, iodantipyrine, ethylmethylhydroxypyridine succinate, etc.)

Group of companies Pik-Pharma (St. Petersburg-Belgorod)
Production of substances and finished products medicines. The company has three production sites. The product portfolio includes 13 drugs.

MBNPK "Cytomed" (St. Petersburg-Finland)
Production of peptide drugs. Production sites in St. Petersburg and Lappenranta.

OJSC "Pharmaceutical Factory of St. Petersburg" (St. Petersburg)
Development, production and sale of medicinal products from herbal raw materials

Samson-Med LLC (St. Petersburg)
Production is carried out according to the following directions: injection forms; infusion solutions; natural hormonal and enzyme preparations.

CJSC "Northern Star" (Len. region, Kuzmolovsky village)
Production of solid dosage forms: tablets and film-coated tablets, hard gelatin capsules. The assortment portfolio consists of about 40 items.

CJSC "Pharmproekt" (St. Petersburg)
Production of finished medicines.

Alkor Bio LLC (St. Petersburg)
Development, production and sale of enzyme immunoassay kits

Pharmacor Production LLC (St. Petersburg)
Production wide range medicines, dietary supplements, as well as packaging production of drugs from leading European companies.

JSC "Medpolymer" (St. Petersburg)
Production medical supplies, products medical purposes and products for dentistry.

LLC "Biotech" (St. Petersburg)
Isolation and purification of recombinant human interleukin-2

OJSC "Pharmstandard" (Moscow)
The company produces more than 200 types of finished medicines. The largest domestic holding

FSUE NPO Microgen, Ministry of Health of the Russian Federation (Moscow)
Development and production of immunobiological, diagnostic and medicinal products

OJSC "Veropharm" (Moscow)
Production of generics, oncology drugs, medical patches.

NPO PETROVAX PHARM (Moscow)
Production original drugs Polyoxidonium, Longidaza, Grippol.

CJSC PharmFirma Sotex (Moscow)
The company's product portfolio includes 67 medicines, including 28 of its own.

OJSC "Valenta Pharmaceuticals" (Moscow region)
Production of solid dosage forms, as well as production of neurological and antimicrobial drugs

LLC "KRKA-RUS" (Moscow region, Istra)
Production of drugs for the treatment of cardiovascular diseases.

JSC "Akrikhin" (Moscow)
GLS production, the company produces about 150 types of drugs

Alkoy LLC (Moscow)
Development and production of homeopathic medicines, medicinal cosmetics and dietary supplements

CJSC "Partner" (Moscow)
Development and production of immunobiological drugs, dietary supplements and food products for the treatment of dysbacteriosis

CJSC "Moscow Pharmaceutical Factory" (Moscow)
Production of tinctures, extracts, ointments, syrups, homeopathic medicines, medical alcohols...

OJSC "Moskhimfarmpreparaty named after N.A. Semashko" (Moscow)
Production of drugs of various pharmacotherapeutic groups, release of pharmaceutical drugs.

CJSC "EKOlab" (Moscow region, Elektrogorsk)
Production of enzyme immunoassay test systems and other diagnostic MIBPs, kits for biochemical, hematological, histological and general clinical laboratory research, as well as GLS.

OJSC "Nizhpharm" (Nizhny Novgorod)
Part of the STADA CIS holding. Production is located on almost 11.5 thousand square meters. meters with workshops for the production of ointments, creams, suppositories, liniments, tablets.

OJSC "Tatkhimfarmpreparaty" (Kazan)
It has two modern plants: a chemical-pharmaceutical plant and a plant for suture-surgical materials. It has production facilities that allow it to annually produce more than 111 types of finished medicines.

OJSC Kurgan "Sintez" (Kurgan)
Production of natural and semi-synthetic antibiotic substances, production of pharmaceutical drugs and honey. plastic products.

CJSC "Evalar" ( Altai region Biysk)
Development and production of natural medicines and parapharmaceuticals

CJSC "Altaivitamins" (Altai Territory, Biysk)
Large manufacturer of pharmaceuticals, biologically active additives natural based, fortified food products and cosmeceuticals

JSC "Biosintez" (Penza)
Production of various pharmaceutical products

OJSC "Novosibkhimpharm" (Novosibirsk)
Specializes in release injection solutions in ampoules and patches.

LLC NPO "SibEnzim" (Novosibirsk)
Production and sale of nucleic acid metabolic enzymes and related drugs.

JSC "Biokhimik" (Saransk)
Produces more than 60 types of drugs: antibiotics, antitumor agents, plasma replacement solutions, diuretics, drugs used for anesthesia, painkillers

OJSC "Kraspharma" (Krasnoyarsk)
Main products: antibiotics, infusions and blood plasma substitutes

JSC "Organika" (Novokuznetsk)
Release of FPP. The main products are drugs acting on the central nervous system.

JSC "Pharmasintez" (Irkutsk)
The country's largest domestic manufacturer of anti-tuberculosis drugs. Among the twenty pharmaceutical companies Russia by production volumes

The largest Russian pharmaceutical companies earned from 15 billion rubles (PJSC Pharmstandard) to 182 billion rubles (JSC NPK Katren) in annual revenue at the end of 2015.

 

In the last two years, 2015 and 2016, the Russian pharmaceutical industry has shown significant growth - more than 20% in 2016, according to the Minister of Industry and Trade of the Russian Federation Denis Manturov.

At a briefing held at the Russian Ministry of Industry and Trade, Deputy Minister Sergei Tsyb said that the best evidence of the growth of the domestic pharmaceutical industry is that the American pharmaceutical giants are outraged: it is difficult for them to break into Russian market, as they are being replaced by large pharmaceutical companies in Russia. We analyzed and prepared the Top 7 largest Russian pharmaceutical holdings by revenue for 2015.

Pharmstandard

Legal address: Moscow

Registration date: 1996

Founders: Minin Alexander Nikolaevich, Kuznetsov Igor Gennadievich.

CEO: Kuznetsov Igor Gennadievich

• Authorized capital: 1,000,012.86 rub.
• Fixed assets: 153,955 thousand rubles
• Revenue: 21,191,811
• Accounts receivable: 2,667,522 thousand rubles
• Accounts payable: 6,961,274 thousand rubles.
• Net profit: 1,042,833 thousand rubles
• Net assets: 2,646,595 thousand rubles
• INN - 7731241639

http://www.euro-service.ru/

Sia International

Joint Stock Company "Sia International LTD" is engaged in the sale of medicines and medical products pharmacies and medical institutions.

It has warehouse complexes in Moscow and more than 35 cities of Russia. Their total area is more than 200 thousand square meters.

Legal address: Moscow city

Registration date: 1995

Founders: JSC "Rink", Rudinsky Igor Feliksovich.

CEO: Demkin Alexander Yurievich

• Authorized capital: 20,000,000 rubles
• Fixed assets: 5,624,687 thousand rubles.
• Revenue: 59,438,184 thousand rubles
• Accounts receivable: 13,597,841 thousand rubles.
• Accounts payable: 20,209,002 thousand rubles.
• Net profit: -3,111,114 thousand rubles
• Net assets: 2,908,224 thousand rubles
• TIN - 7714030099

Sources: official website: http://siamed.ru/, extract from the Unified State Register of Legal Entities, Rosstat (financial reporting data according to RAS for 2015).

R-Pharm

Joint Stock Company "R-Pharm" specializes in high-tech medicines. Currently, the company is working towards large-scale investment projects.

It is creating a production base as part of the state strategy for the development of the Russian pharmaceutical industry until 2020.

Legal address: Moscow

Registration date: year 2001

Founders: Repik Alexey Evgenievich

CEO: Ignatiev Vasily Gennadievich

• Authorized capital: RUB 28,400.
• Fixed assets: 2,119,636 thousand rubles
• Revenue: 62,204,014 thousand rubles
• Accounts receivable: 13,435,674 thousand rubles.
• Accounts payable: 30,682,362 thousand rubles
• Net profit: 8,608,010 thousand rubles.
• Net assets: 24,205,818 thousand rubles
• INN - 7726311464

Sources of information: official website: http://r-pharm.com, extract from the Unified State Register of Legal Entities, Rosstat (financial reporting data according to RAS for 2015).

Growth

Closed Joint-Stock Company"Growth." In total, the Rosta pharmaceutical group includes 4 companies: Rosta (engaged in the distribution of medicines), Rosta Marketing (trade marketing), Raduga Production (plant for the production of solid medicines), United Pharmacy Chain, which includes the companies “Rainbow”, “First Aid”, “Ladushka”.

Legal address: Moscow region, city of Podolsk

Registration date: 2002

Founders: Joint Stock Company PJSC "Tampo", Mirilashvili Mikhail Mikhailovich, Panikashvili David Isaakovich, Tseytlin Oleg Yakovlevich, Strepetov Vadim Valentinovich, Shepel Boris Albertovich, Semenyuk Alexander Vasilievich, Konev Oleg Yurievich.

The president: Panikashvili David Isaakovich

• Authorized capital: 1,000,000 rubles
• Fixed assets: 621,356 thousand rubles
• Revenue:63,384,563 thousand rubles
• Accounts receivable: 18,293,282 thousand rubles.
• Accounts payable: 35,244,901 thousand rubles
• Net profit: 415,314 thousand rubles
• Net assets: 1,755,002 thousand rubles.
• INN - 7726320638

Sources: official website: http://www.rostagroup.ru/, extract from the Unified State Register of Legal Entities, Rosstat (financial reporting data according to RAS for 2015).

Protek

Closed joint stock company firm "Implementation Center "Protek". The Protek group of companies is engaged in the production, distribution and retail sale of medicines through pharmacy chains.

The holding's production and technological capacities comply with GMP standards.

Legal address: Moscow

Registration date: 1994

Founders: JSC "Protek"

CEO: Pogrebinsky Dmitry Borisovich

• Authorized capital: 40,000,000 rubles
• Fixed assets: 1,082,865 thousand rubles.
• Revenue: 166,578,310 thousand rubles
• Accounts receivable: 32,742,113 thousand rubles.
• Accounts payable: 69,059,867 thousand rubles
• Net profit: RUB 5,419,719.
• Net assets: 8,094,159 rubles
• INN - 7724053916

Sources of information: official website of the company: http://www.protek-group.ru, extract from the Unified State Register of Legal Entities, Rosstat (financial reporting data according to RAS for 2015).

Quatrain

The geography of Katren's work covers 85 constituent entities of the Russian Federation and delivers more than 18 thousand types of pharmaceutical products.

Legal address: city ​​Novosibirsk

Registration date: 1993

Founders: Konobeev Leonid Valentinovich, Spiridonov Vladimir Nikolaevich

CEO: Konobeev Leonid Valentinovich

• Authorized capital: 1 billion 500 million rubles
• Fixed assets: 6,752,880 thousand rubles
• Revenue: 182,301,551 thousand rubles
• Accounts receivable: 30,155,368 thousand rubles.
• Accounts payable: 65,656,588 thousand rubles
• Net profit: 5,790,742 thousand rubles
• Net assets: 11,103,940 thousand rubles.
• INN - 5408130693

Sources: official website: http://katren.ru, extract from the Unified State Register of Legal Entities, Rosstat (financial reporting data according to RAS for 2015).

Read about the project

When you buy a product or service from someone, you give him money for development, finance him (help). If you don't buy, you don't help (don't finance). By buying Russian goods and services, you help Russian people. This is reasonable for you if you are part of the Russian people.

Dmitry Mezentsev

Subscribe to RUSSIANSOYUZRF @russkii_souz

The information you add must meet our selection criteria

• Russian manufacturers- these are Russian production owners who produce goods on the territory of their country, registered in it and using the labor of Russian workers. Accordingly, they produce Russian goods.
• Russian owners or co-owners of production, using anything foreign in the production process (companions, workers, territory, etc.) are placed in the section “Production with Russian participation" Accordingly, they produce goods with Russian participation.
• Russian sellers- these are Russian entrepreneurs who use the labor of Russian workers and sell Russian goods or goods with Russian participation. If the store has at least one shelf with Russian goods, then the store can be placed in the catalog and advertise these goods.
• Russian services provided by Russian entrepreneurs who use the labor of Russian workers and strive, if possible, to use Russian goods.

Also be sure to check out

Over the past 12 months, the pharmaceutical market has demonstrated strong growth, which means that the income of drug manufacturers is growing steadily. Pharmaceuticals are traditionally considered one of the most profitable sectors of the economy.

However, entering this market is not at all easy, because large manufacturers invest billions of dollars in drug development, patenting and sales. Today we present rating of the largest pharmaceutical companies, which presents the world's main players in the medicinal industry.

The company was founded in 1863 in Germany. Bayer produces medications for people and animals, nutritional supplements, as well as agrochemical fertilizers.

9.Merck & Co

The headquarters of this pharmaceutical company is located in New Jersey, USA. Merck & Co. was founded in 1891 as a subsidiary of the German company Merck KGaA. During the war the department was confiscated American government and became an independent company.

8. Abbott Laboratories

The American pharmaceutical company was founded in 1888. And in 2010, Abbott Laboratories' turnover exceeded $35 billion. The company employs more than 91 thousand people.

The Swedish-British company was founded in 1999 by merging the Swedish Astra AB with the British Zeneca. AstraZeneca's turnover is about $25 billion. Today the pharmaceutical company employs more than 50 thousand people.

A French pharmaceutical company produces drugs for various diseases, vaccines, oncology drugs, etc. At the same time, Sanofi is an employer of 112 thousand people.

The Swiss company was founded in 1996. Novartis' subsidiary brands are manufacturers contact lenses Alcon and Ciba Vision, as well as pharmaceutical company Sandoz.

The British pharmaceutical company has offices in 114 countries. GSK operates 24 research and development laboratories. The company's employees are 99 thousand people.

The Swiss holding is active in the market of innovative drugs. F. Hoffmann-La Roche owns three subsidiaries operating in the field of biotechnology. The holding is an employer of 85 thousand people.

The American company was founded in 1849 by two cousins, immigrants from Germany. The company's turnover today exceeds $51 billion. Pfizer employees are 78 thousand people.